PHARMACOKINETICS OF SUBCUTANEOUS AZIDOTHYMIDINE IN RHESUS-MONKEYS

[1] PHARMACOKINETICS OF SUBCUTANEOUS METHOTREXATE [J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (12) : 1882 - 1886

[2] THE PHARMACOKINETICS OF ZIDOVUDINE ADMINISTERED BY CONTINUOUS INFUSION IN CHILDREN [J]. ANNALS OF INTERNAL MEDICINE, 1989, 110 (04) : 279 - 285

[3] BRUERA E, 1988, CANCER-AM CANCER SOC, V62, P407, DOI 10.1002/1097-0142(19880715)62:2<407::AID-CNCR2820620227>3.0.CO

[4] 2-T

[5] THE EFFICACY OF AZIDOTHYMIDINE (AZT) IN THE TREATMENT OF PATIENTS WITH AIDS AND AIDS-RELATED COMPLEX - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (04) : 185 - 191

[6] Gibaldi M., 1982, PHARMACOKINETICS, P445

[7] HUSSAIN MAM, 1976, LANCET, V2, P1278

[8] PLASMA AND CEREBROSPINAL-FLUID PHARMACOKINETICS OF 3'-AZIDO-3'-DEOXYTHYMIDINE - A NOVEL PYRIMIDINE ANALOG WITH POTENTIAL APPLICATION FOR THE TREATMENT OF PATIENTS WITH AIDS AND RELATED DISEASES [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (04) : 407 - 412

[9] 3'-AZIDO-3'-DEOXYTHYMIDINE (BW A509U) - AN ANTIVIRAL AGENT THAT INHIBITS THE INFECTIVITY AND CYTOPATHIC EFFECT OF HUMAN LYMPHOTROPIC-T VIRUS TYPE-III LYMPHADENOPATHY-ASSOCIATED VIRUS INVITRO [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (20) : 7096 - 7100

[10] NON-COMPARTMENTAL DETERMINATION OF THE STEADY-STATE VOLUME OF DISTRIBUTION FOR ANY MODE OF ADMINISTRATION [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (03) : 372 - 373

[1] PHARMACOKINETICS OF SUBCUTANEOUS METHOTREXATE [J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (12) : 1882 - 1886

[2] THE PHARMACOKINETICS OF ZIDOVUDINE ADMINISTERED BY CONTINUOUS INFUSION IN CHILDREN [J]. ANNALS OF INTERNAL MEDICINE, 1989, 110 (04) : 279 - 285

[3] BRUERA E, 1988, CANCER-AM CANCER SOC, V62, P407, DOI 10.1002/1097-0142(19880715)62:2<407::AID-CNCR2820620227>3.0.CO

[4] 2-T

[5] THE EFFICACY OF AZIDOTHYMIDINE (AZT) IN THE TREATMENT OF PATIENTS WITH AIDS AND AIDS-RELATED COMPLEX - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (04) : 185 - 191

[6] Gibaldi M., 1982, PHARMACOKINETICS, P445

[7] HUSSAIN MAM, 1976, LANCET, V2, P1278

[8] PLASMA AND CEREBROSPINAL-FLUID PHARMACOKINETICS OF 3'-AZIDO-3'-DEOXYTHYMIDINE - A NOVEL PYRIMIDINE ANALOG WITH POTENTIAL APPLICATION FOR THE TREATMENT OF PATIENTS WITH AIDS AND RELATED DISEASES [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (04) : 407 - 412

[9] 3'-AZIDO-3'-DEOXYTHYMIDINE (BW A509U) - AN ANTIVIRAL AGENT THAT INHIBITS THE INFECTIVITY AND CYTOPATHIC EFFECT OF HUMAN LYMPHOTROPIC-T VIRUS TYPE-III LYMPHADENOPATHY-ASSOCIATED VIRUS INVITRO [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (20) : 7096 - 7100

[10] NON-COMPARTMENTAL DETERMINATION OF THE STEADY-STATE VOLUME OF DISTRIBUTION FOR ANY MODE OF ADMINISTRATION [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (03) : 372 - 373